Cargando…

Intrauterine programming of obesity and type 2 diabetes

The type 2 diabetes epidemic and one of its predisposing factors, obesity, are major influences on global health and economic burden. It is accepted that genetics and the current environment contribute to this epidemic; however, in the last two decades, both human and animal studies have consolidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Twinn, Denise S., Hjort, Line, Novakovic, Boris, Ozanne, Susan E., Saffery, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731191/
https://www.ncbi.nlm.nih.gov/pubmed/31451874
http://dx.doi.org/10.1007/s00125-019-4951-9
_version_ 1783449637298896896
author Fernandez-Twinn, Denise S.
Hjort, Line
Novakovic, Boris
Ozanne, Susan E.
Saffery, Richard
author_facet Fernandez-Twinn, Denise S.
Hjort, Line
Novakovic, Boris
Ozanne, Susan E.
Saffery, Richard
author_sort Fernandez-Twinn, Denise S.
collection PubMed
description The type 2 diabetes epidemic and one of its predisposing factors, obesity, are major influences on global health and economic burden. It is accepted that genetics and the current environment contribute to this epidemic; however, in the last two decades, both human and animal studies have consolidated considerable evidence supporting the ‘developmental programming’ of these conditions, specifically by the intrauterine environment. Here, we review the various in utero exposures that are linked to offspring obesity and diabetes in later life, including epidemiological insights gained from natural historical events, such as the Dutch Hunger Winter, the Chinese famine and the more recent Quebec Ice Storm. We also describe the effects of gestational exposure to endocrine disruptors, maternal infection and smoking to the fetus in relation to metabolic programming. Causal evidence from animal studies, motivated by human observations, is also discussed, as well as some of the proposed underlying molecular mechanisms for developmental programming of obesity and type 2 diabetes, including epigenetics (e.g. DNA methylation and histone modifications) and microRNA interactions. Finally, we examine the effects of non-pharmacological interventions, such as improving maternal dietary habits and/or increasing physical activity, on the offspring epigenome and metabolic outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4951-9) contains a slideset of the figures for download, which is available to authorised users.
format Online
Article
Text
id pubmed-6731191
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-67311912019-09-20 Intrauterine programming of obesity and type 2 diabetes Fernandez-Twinn, Denise S. Hjort, Line Novakovic, Boris Ozanne, Susan E. Saffery, Richard Diabetologia Review The type 2 diabetes epidemic and one of its predisposing factors, obesity, are major influences on global health and economic burden. It is accepted that genetics and the current environment contribute to this epidemic; however, in the last two decades, both human and animal studies have consolidated considerable evidence supporting the ‘developmental programming’ of these conditions, specifically by the intrauterine environment. Here, we review the various in utero exposures that are linked to offspring obesity and diabetes in later life, including epidemiological insights gained from natural historical events, such as the Dutch Hunger Winter, the Chinese famine and the more recent Quebec Ice Storm. We also describe the effects of gestational exposure to endocrine disruptors, maternal infection and smoking to the fetus in relation to metabolic programming. Causal evidence from animal studies, motivated by human observations, is also discussed, as well as some of the proposed underlying molecular mechanisms for developmental programming of obesity and type 2 diabetes, including epigenetics (e.g. DNA methylation and histone modifications) and microRNA interactions. Finally, we examine the effects of non-pharmacological interventions, such as improving maternal dietary habits and/or increasing physical activity, on the offspring epigenome and metabolic outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-4951-9) contains a slideset of the figures for download, which is available to authorised users. Springer Berlin Heidelberg 2019-08-27 2019 /pmc/articles/PMC6731191/ /pubmed/31451874 http://dx.doi.org/10.1007/s00125-019-4951-9 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Fernandez-Twinn, Denise S.
Hjort, Line
Novakovic, Boris
Ozanne, Susan E.
Saffery, Richard
Intrauterine programming of obesity and type 2 diabetes
title Intrauterine programming of obesity and type 2 diabetes
title_full Intrauterine programming of obesity and type 2 diabetes
title_fullStr Intrauterine programming of obesity and type 2 diabetes
title_full_unstemmed Intrauterine programming of obesity and type 2 diabetes
title_short Intrauterine programming of obesity and type 2 diabetes
title_sort intrauterine programming of obesity and type 2 diabetes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731191/
https://www.ncbi.nlm.nih.gov/pubmed/31451874
http://dx.doi.org/10.1007/s00125-019-4951-9
work_keys_str_mv AT fernandeztwinndenises intrauterineprogrammingofobesityandtype2diabetes
AT hjortline intrauterineprogrammingofobesityandtype2diabetes
AT novakovicboris intrauterineprogrammingofobesityandtype2diabetes
AT ozannesusane intrauterineprogrammingofobesityandtype2diabetes
AT safferyrichard intrauterineprogrammingofobesityandtype2diabetes